NT5C and idiopathic pulmonary fibrosis: This study adopts an integrated framework of “computational prediction–experimental validation” to systematically elucidate the anti-IPF mechanism of action of CDN, which mainly consists of three steps: First, it utilizes network pharmacology to screen the potential human targets of CDN, intersect these targets with IPF-related targets, construct a core interaction network, and identify candidate pathways.